| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.22 | 7e-05 |